RxDoctor Payments Data

Stephen Ionna, MD

Gastroenterology · Cincinnati, OHNPI 1174527659

Payments from drug & device makers

$3,968in general payments, 2019–2025

Across 321 payments — averaging $12.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$504
  • Johnson & Johnson$355
  • Takeda Pharmaceuticals U.S.A., Inc.$321
  • Bristol Myers Squibb$203
  • Ironwood Pharmaceuticals, Inc$174
  • plus $785 from 20 others

What the payments were for

  • Food & beverage$3,75395%
  • Education$2155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,968 in reported general payments places this provider in the 55th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$177,236
Medicare patients
821
Services billed
1,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab13$360,627
Humira(Cf) PenAdalimumab26$334,729
ZenpepLipase/Protease/Amylase14$81,699
XifaxanRifaximin16$54,064
CreonLipase/Protease/Amylase13$32,709
LinzessLinaclotide36$24,615
Mesalamine30$15,408
Lansoprazole23$8,560
Ursodiol23$5,161
Pantoprazole Sodium472$4,978
SutabSod Sulf/Pot Chloride/Mag Sulf21$3,388
Mesalamine ErMesalamine13$3,078
Balsalazide Disodium15$2,683
Budesonide EcBudesonide13$2,510
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C16$2,310

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$355$360,62713 claims
AbbVieCreon, Linzess$1,626$57,32349 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Plenvu$504$56,37432 claims
Braintree Laboratories, Inc.Sutab$55$3,38821 claims
Ferring Pharmaceuticals Inc.Clenpiq$96$2,25013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →